PMID- 34020271 OWN - NLM STAT- MEDLINE DCOM- 20210622 LR - 20210622 IS - 1090-2414 (Electronic) IS - 0147-6513 (Linking) VI - 219 DP - 2021 Aug TI - Role of Clusterin/NF-kappaB in the secretion of senescence-associated secretory phenotype in Cr(VI)-induced premature senescent L-02 hepatocytes. PG - 112343 LID - S0147-6513(21)00454-1 [pii] LID - 10.1016/j.ecoenv.2021.112343 [doi] AB - Hexavalent chromium [Cr(VI)] and its compounds have caused serious environmental pollution and health damage. Senescent cells can actively change the surrounding environment by secreting some factors, which are called senescence associated secretory phenotype (SASP). Our previous work has confirmed that premature senescent hepatocytes induced by Cr(VI) expressed high level of Clusterin (CLU) and secrete interleukin-6 (IL-6) and IL-8. CLU is involved in the regulation of tumor development and drug resistance, but whether CLU regulates SASP components and participates in Cr(VI)-induced malignant transformation is unclear. In this study we demonstrated that Cr(VI) induced the secretion of tumor promoting components of SASP such as IL-6, IL-8, and granulocyte-macrophage colony stimulating factor (GM-CSF) in senescent L-02 hepatocytes, while the levels of the anti-tumor components of SASP such as chemokine (c-x-c motif) ligand-1 (CXCL-1) and monocyte chemoattractant protein-1 (MCP-1) were not altered. CLU shRNA interference significantly reduced the levels of IL-6, IL-8, and GM-CSF in the culture medium of senescent cells, suggesting CLU may regulate SASP. The NF-kappaB inhibitor PDTC significantly alleviated Cr(VI)-induced increase of IL-6, IL-8, and GM-CSF, confirming that NF-kappaB can regulate the tumor promoting components of SASP. CLU shRNA interference aggravated the inhibitory effect of PDTC on SASP secretion, indicating that CLU regulated the secretion of SASP in Cr(VI)-induced senescent hepatocytes through the NF-kappaB signaling. We speculated that SASP secreted by Cr(VI)-induced premature senescent hepatocytes was tightly related to the carcinogenic effect of Cr(VI). Therefore, elucidation of upstream regulatory mechanism of SASP is of great significance. In addition to further clarifying the carcinogenic mechanisms associated with Cr(VI), we could also seek out new targets for treatment of Cr(VI)-related cancer. CI - Copyright (c) 2021 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Liang, Yuehui AU - Liang Y AD - Xiangya School of Public Health, Central South University, Changsha 410078, PR China. FAU - Liang, Ningjuan AU - Liang N AD - Xiangya School of Public Health, Central South University, Changsha 410078, PR China. FAU - Ma, Yu AU - Ma Y AD - Xiangya School of Public Health, Central South University, Changsha 410078, PR China. FAU - Tang, Sixuan AU - Tang S AD - Xiangya School of Public Health, Central South University, Changsha 410078, PR China. FAU - Ye, Shuzi AU - Ye S AD - Xiangya School of Public Health, Central South University, Changsha 410078, PR China. FAU - Xiao, Fang AU - Xiao F AD - Xiangya School of Public Health, Central South University, Changsha 410078, PR China. Electronic address: fangxiao@csu.edu.cn. LA - eng PT - Journal Article DEP - 20210518 PL - Netherlands TA - Ecotoxicol Environ Saf JT - Ecotoxicology and environmental safety JID - 7805381 RN - 0 (Clusterin) RN - 0 (Interleukin-6) RN - 0 (NF-kappa B) RN - 0 (RELA protein, human) RN - 0 (Transcription Factor RelA) RN - 0R0008Q3JB (Chromium) RN - 18540-29-9 (chromium hexavalent ion) SB - IM MH - Cellular Senescence/drug effects MH - Chromium/*toxicity MH - Clusterin/*metabolism MH - Hepatocytes/drug effects MH - Humans MH - Interleukin-6 MH - NF-kappa B/*metabolism MH - Phenotype MH - Signal Transduction/drug effects MH - Transcription Factor RelA OTO - NOTNLM OT - Clusterin OT - Hexavalent chromium [Cr(VI)] OT - Nuclear factor-kappa B (NF-kappaB) OT - Premature senescence OT - Senescence-associated secretory phenotype (SASP) EDAT- 2021/05/22 06:00 MHDA- 2021/06/23 06:00 CRDT- 2021/05/21 20:25 PHST- 2020/12/31 00:00 [received] PHST- 2021/05/10 00:00 [revised] PHST- 2021/05/12 00:00 [accepted] PHST- 2021/05/22 06:00 [pubmed] PHST- 2021/06/23 06:00 [medline] PHST- 2021/05/21 20:25 [entrez] AID - S0147-6513(21)00454-1 [pii] AID - 10.1016/j.ecoenv.2021.112343 [doi] PST - ppublish SO - Ecotoxicol Environ Saf. 2021 Aug;219:112343. doi: 10.1016/j.ecoenv.2021.112343. Epub 2021 May 18.